Provision of Italian diagnostic reference levels for diagnostic and interventional radiology.

OBJECTIVES: The diagnostic reference level (DRL) is a useful tool for the optimisation of medical exposures. Thus, a Working Party coordinated by the Italian National Institute of Health and the National Workers Compensation Authority has been formed to provide Italian DRLs, for both diagnostic and interventional procedures, to be used as appropriate for the implementation of the 2013/59 European Directive into the national regulation. MATERIALS AND METHODS: The multidisciplinary Working Party was formed by professionals involved in diagnostic and interventional radiology medical exposures and started from a critical revision of both the literature and the results of previous Italian surveys. The procedures were divided into five sections for adult (projection radiography, mammography, diagnostic fluoroscopy, CT and interventional radiology) and two sections for paediatric patients (projection radiography and CT). The provided DRL values have been identified for "normal" adult patients and for age-classes of paediatric patients. RESULTS: Some of the DRL values provided by the Working Party are reported in this study as an example, divided by adult/paediatric patients, radiological technique and examination: specifically, DRLs for new radiological practices and new dose quantities as DRLs metric were introduced. The median value (rather than the mean) for each procedure, derived from a sample of patients, has to be compared with the corresponding DRL value, and dosimetric data related to a minimum number of patients should be collected for each examination. CONCLUSIONS: The approach to the definition and use of DRLs through guidelines of national Authorities in collaboration with scientific Associations should simplify the periodical updating and could be useful for keeping the optimisation of medical exposures faithful to the development of radiological practice.

DNA damage in lens epithelial cells exposed to occupationally-relevant X-ray doses and role in cataract formation.

The current framework of radiological protection of occupational exposed medical workers reduced the eye-lens equivalent dose limit from 150 to 20 mSv per year requiring an accurate dosimetric evaluation and an increase understanding of radiation induced effects on Lens cells considering the typical scenario of occupational exposed medical operators. Indeed, it is widely accepted that genomic damage of Lens epithelial cells (LEC) is a key mechanism of cataractogenesis. However, the relationship between apoptosis and cataractogenesis is still controversial. In this study biological and physical data are combined to improve the understanding of radiation induced effects on LEC. To characterize the occupational exposure of medical workers during angiographic procedures an INNOVA 4100 (General Electric Healthcare) equipment was used (scenario A). Additional experiments were conducted using a research tube (scenario B). For both scenarios, the frequencies of binucleated cells, micronuclei, p21-positive cells were assessed with different doses and dose rates. A Monte-Carlo study was conducted using a model for the photon generation with the X-ray tubes and with the Petri dishes considering the two different scenarios (A and B) to reproduce the experimental conditions and validate the irradiation setups to the cells. The simulation results have been tallied using the Monte Carlo code MCNP6. The spectral characteristics of the different X-ray beams have been estimated. All irradiated samples showed frequencies of micronuclei and p21-positive cells higher than the unirradiated controls. Differences in frequencies increased with the delivered dose measured with Gafchromic films XR-RV3. The spectrum incident on eye lens and Petri, as estimated with MCNP6, was in good agreement in the scenario A (confirming the experimental setup), while the mean energy spectrum was higher in the scenario B. Nevertheless, the response of LEC seemed mainly related to the measured absorbed dose. No effects on viability were detected. Our results support the hypothesis that apoptosis is not responsible for cataract induced by low doses of X-ray (i.e. 25 mGy) while the induction of transient p21 may interfere with the disassembly of the nuclear envelop in differentiating LEC, leading to cataract formation. Further studies are needed to better clarify the relationship we suggested between DNA damage, transient p21 induction and the inability of LEC enucleation.

HPV DNA Associates With Breast Cancer Malignancy and It Is Transferred to Breast Cancer Stromal Cells by Extracellular Vesicles.

A causal link between Human Papillomavirus (HPV) and breast cancer (BC) remains controversial. In spite of this, the observation that HPV DNA is over-represented in the Triple Negative (TN) BC has been reported. Here we remark the high prevalence of HPV DNA (44.4%) in aggressive BC subtypes (TN and HER2+) in a population of 273 Italian women and we convey the presence of HPV DNA in the epithelial and stromal compartments by in situ hybridization. As previously reported, we also found that serum derived-extracellular vesicles (EVs) from BC affected patients contain HPV DNA. Interestingly, in one TNBC patient, the same HPV DNA type was detected in the serum-derived EVs, cervical and BC tissue samples. Then, we report that HPV DNA can be transferred by EVs to recipient BC stromal cells that show an activated phenotype (e.g., CD44, IL6 expression) and an enhanced capability to sustain mammospheres (MS) formation. These data suggest that HPV DNA vehiculated by EVs is a potential trigger for BC niche aggressiveness.

Hibernation and Radioprotection: Gene Expression in the Liver and Testicle of Rats Irradiated under Synthetic Torpor.

Hibernation has been proposed as a tool for human space travel. In recent years, a procedure to induce a metabolic state known as "synthetic torpor" in non-hibernating mammals was successfully developed. Synthetic torpor may not only be an efficient method to spare resources and reduce psychological problems in long-term exploratory-class missions, but may also represent a countermeasure against cosmic rays. Here we show the preliminary results from an experiment in rats exposed to ionizing radiation in normothermic conditions or synthetic torpor. Animals were irradiated with 3 Gy X-rays and organs were collected 4 h after exposure. Histological analysis of liver and testicle showed a reduced toxicity in animals irradiated in torpor compared to controls irradiated at normal temperature and metabolic activity. The expression of ataxia telangiectasia mutated (ATM) in the liver was significantly downregulated in the group of animal in synthetic torpor. In the testicle, more genes involved in the DNA damage signaling were downregulated during synthetic torpor. These data show for the first time that synthetic torpor is a radioprotector in non-hibernators, similarly to natural torpor in hibernating animals. Synthetic torpor can be an effective strategy to protect humans during long term space exploration of the solar system.

Summary of the Italian inter-society recommendations for radiation protection optimization in interventional radiology.

OBJECTIVES: A Working Group coordinated by the Italian National Institute of Health (Istituto Superiore di Sanità) and the National Workers Compensation Authority (Istituto Nazionale per l'Assicurazione contro gli Infortuni sul Lavoro, INAIL) and consisting of 11 Italian scientific/professional societies involved in the fluoroscopically guided interventional practices has been established to define recommendations for the optimization of patients and staff radiation protection in interventional radiology. A summary of these recommendations is here reported. MATERIALS AND METHODS: A multidisciplinary approach was used to establish the Working Group by involving radiologists, interventional radiologists, neuroradiologists, interventional cardiologists, occupational health specialists, medical physicists, radiation protection experts, radiographers and nurses. The Group operated as a "Consensus Conference". Three main topics have been addressed: patient radiation protection (summarized in ten "golden rules"); staff radiation protection (summarized in ten "golden rules"); and education/training of interventional radiology professionals. RESULTS: In the "golden rules", practical and operational recommendations were provided to help the professionals in optimizing dose delivered to patients and reducing their own exposure. Operative indications dealt also with continuing education and training, and recommendations on professional accreditation and certification. CONCLUSIONS: The "Consensus Conference" was the methodology adopted for the development of these recommendations. Involvement of all professionals is a winning approach to improve practical implementation of the recommendations, thus getting a real impact on the optimization of the interventional radiology practices.

Preoperative Chemoradiation With VMAT-SIB in Rectal Cancer: A Phase II Study.

PURPOSE: The aim of this study was to investigate the efficacy and toxicity of volumetric modulated arc therapy (VMAT)-simultaneous integrated boost (SIB) in preoperative combined treatment of locally advanced rectal cancer. METHODS: Radiation therapy was performed using the VMAT-SIB technique. The dose to mesorectum and pelvic lymph nodes was 45 Gy (1.8 Gy/fraction). A concomitant boost was delivered on GTV + 2-cm margin with a total dose of 57.5 Gy (2.3 Gy/fraction). The following concomitant chemotherapy was administered: capecitabine (825 mg/m2 twice daily, 5 days per week) and oxaliplatin (130 mg/m2 on days 1, 17, and 35). Efficacy was evaluated in terms of complete pathological response (pCR). Acute toxicities were evaluated according to Common Terminology Criteria for Adverse Events version 3.0 criteria. RESULTS: A total of 18 patients (7 women; median age 62 years; clinical stage: 4 local recurrences, 6 cT4, 5 cT3, 3 cT2, 2 cN0, 7 cN1, 9 cN2) were enrolled. Sixteen patients underwent surgical resection (9 low anterior resection, 6 abdominal perineal amputations; 1 transanal excision) and 2 patients did not undergo surgery for early metastatic progression or death from acute pulmonary edema. R0 resection was achieved in all patients who underwent surgery. Overall, 4 patients had a pCR and 7 patients only a microscopic residual of disease (pT0-Tmic: 11/18 = 61.1%; 95% CI, 36.2-86.1). Acute grade ≥ 3 toxicity was as follows: 1 case of leukopenia, 1 skin toxicity, 1 genitourinary toxicity, and 5 gastrointestinal toxicities, with an overall incidence of 8 (44.4%) of 18 patients. One-, 3-, and 5-year cumulative local control was 100%, 68.6%, and 68.6%, respectively. One-, 3-, and 5-year cumulative disease-free survival was 88.9%, 66.7%, and 66.7%, respectively. One-, 3-, and 5-year cumulative overall survival was 85%, 63.8%, and 63.8%, respectively. CONCLUSION: The regimen used in this study showed excellent results in terms of pathologic responses. However, despite the use of the VMAT technique, more than one-third of patients had severe acute toxicity.

Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in Patients With Brain Oligometastases: A Phase 1 Study (ISIDE-BM-1).

PURPOSE: To investigate the maximum tolerated dose of intensity modulated radiation therapy simultaneous integrated boost whole-brain radiation therapy for palliative treatment of patients with <5 brain metastases using a standard linear accelerator. MATERIALS AND METHODS: The whole brain plus 3-mm margin was defined as the planning target volume (PTVwb), whereas each brain metastasis, defined as the contrast-enhancing tumor on MRI T1 scans, plus a 3-mm isotropic margin, was defined as metastases PTV (PTVm). Radiation therapy was delivered in 10 daily fractions (2 weeks). Only the dose to PTVm was progressively increased in the patient cohorts (35 Gy, 40 Gy, 45 Gy, 50 Gy), whereas the PTVwb was always treated with 30 Gy (3 Gy per fraction) in all patients. The dose-limiting toxicity was evaluated providing that 3 months of follow-up had occurred after the treatment of a 6-patient cohort. RESULTS: Thirty patients were enrolled in the study (dose PTVm: 35 Gy, 8 patients; 40 Gy, 6 patients; 45 Gy, 6 patients; 50 Gy, 10 patients). The number of treated brain metastases was 1 in 18 patients, 2 in 5 patients, 3 in 6 patients, and 4 in 1 patient. Three patients experienced dose-limiting toxicity: 1 patient at dose level 2 presented grade 3 (G3) skin toxicity; 1 patient at dose level 4 presented G3 neurologic toxicity; and 1 patient at the same level showed brain hemorrhage. Most patients showed G1 to 2 acute toxicity, in most cases skin (n=19) or neurologic (n=10). Twenty-seven were evaluable for response: 6 (22%) stable disease, 18 (67%) partial response, and 3 (11%) complete response. Median survival and 1-year overall survival were 12 months and 53%, respectively. No patient showed late toxicity. CONCLUSIONS: In this first prospective trial on the use of intensity modulated radiation therapy simultaneous integrated boost delivered with a standard linear accelerator in patients with brain oligometastases, a boost dose up to 50 Gy in 10 fractions was tolerable according to the study design.

Radiation-induced mesothelioma among long-term solid cancer survivors: a longitudinal analysis of SEER database.

We investigated the association between external beam radiotherapy (EBRT) and pleural and peritoneal mesothelioma among long-term (>5 years) solid cancer survivors. We analyzed data from the US Surveillance, Epidemiology, and End Results (SEER) program (1973-2012). We fitted survival models adjusted by age, gender, race, year, surgery, and relative risk of primary mesothelioma in the county of residence (proxy for individual asbestos exposure). We estimated hazard ratios [HR] with reference to nonirradiated patients. We distinguished between scattered and direct irradiation to study the dose-response. We observed 301 mesotheliomas (265 pleural; 32 peritoneal; 4 others) among 935,637 patients. EBRT increased the risk of mesothelioma (any site; HR 1.34, 95% CI 1.04-1.77). We observed an increased risk of pleural mesothelioma (HR for EBRT 1.34, 95% CI 1.01-1.77), but we did not find signs of a dose-response relationship (HR for scattered irradiation 1.38; HR for direct irradiation 1.23). On the opposite, only direct peritoneal irradiation was associated with peritoneal mesothelioma (HR 2.20, 95% CI 0.99-4.88), particularly for latencies ≥10 years (HR 3.28, 95% CI 1.14-9.43). A competing risks analysis revealed that the clinical impact of radiation-induced mesothelioma was limited by the high frequency of competing events. The cumulative incidence function of mesothelioma after 40 years of observation was very low (nonirradiated patients 0.00032, irradiated patients 0.00055).EBRT might be a determinant of mesothelioma. Longer latency periods are associated with higher risks, while the dose-response seems nonlinear. The clinical impact of mesothelioma after EBRT for primary solid cancers is limited.

X-ray population exposure from projection radiology and computed tomography in Emilia-Romagna from 2001 to 2010: comparison of ICRP 60 and ICRP 103 weighting factors.

PURPOSE: This paper shows the trends from 2001 to 2010 of per caput and collective effective dose (S) to the Emilia-Romagna population due to radiation exposure from projection radiology (PR) and computed tomography (CT), calculated according to both ICRP60 and ICRP103 tissue weighting factors. MATERIALS AND METHODS: The frequency of examinations and dose calculations were based on data provided directly by Emilia-Romagna Health Trusts. In particular, effective doses were evaluated using the tissue weighting (w T) factors reported both in ICRP60 (w T,60) and in ICRP103 (w T,103). RESULTS: A decrease in the frequency of PR skull examinations and an increase in the frequency of mammography, CT of the abdomen, chest, and head-neck were found during the decade. In 2010, the PR/CT procedures contributed 75.4 %/24.6 % to examination frequency and approximately 10 %/90 % to dose; S was 6,169.2 man Sv when w T,60 was used and 5,855.1-6,665.5 man Sv when w T,103 in two different mathematical models was utilised. CONCLUSIONS: Dose estimates pre- and post-ICRP103 must be compared carefully, because changes due to different radiological practices could be confused with changes due to the use of different w T's. In general, dose evaluations with the use of w T,60 until 2007 and w T,103 from 2008 seem to be consistent and coherent.

Calculation of conversion factors for effective dose for various interventional radiology procedures.

PURPOSE: To provide dose-area-product (DAP) to effective dose (E) conversion factors for complete interventional procedures, based on in-the-field clinical measurements of DAP values and using tabulated E/DAP conversion factors for single projections available from the literature. METHODS: Nine types of interventional procedures were performed on 84 patients with two angiographic systems. Different calibration curves (with and without patient table attenuation) were calculated for each DAP meter. Clinical and dosimetric parameters were recorded in-the-field for each projection and for all patients, and a conversion factor linking DAP and effective doses was derived for each complete procedure making use of published, Monte Carlo calculated conversion factors for single static projections. RESULTS: Fluoroscopy time and DAP values for the lowest-dose procedure (biliary drainage) were approximately 3-fold and 13-fold lower, respectively, than those for the highest-dose examination (transjugular intrahepatic portosystemic shunt, TIPS). Median E/DAP conversion factors from 0.12 (abdominal percutaneous transluminal angioplasty) to 0.25 (Nephrostomy) mSvGy(-1) cm(-2) were obtained and good correlations between E and DAP were found for all procedures, with R(2) coefficients ranging from 0.80 (abdominal angiography) to 0.99 (biliary stent insertion, Nephrostomy and TIPS). The DAP values obtained in this study showed general consistency with the values provided in the literature and median E values ranged from 4.0 mSv (biliary drainage) to 49.6 mSv (TIPS). CONCLUSIONS: Values of E/DAP conversion factors were derived for each procedure from a comprehensive analysis of projection and dosimetric data: they could provide a good evaluation for the stochastic effects. These results can be obtained by means of a close cooperation between different interventional professionals involved in patient care and dose optimization.

Survey of the interventional cardiology procedures in Italy.

Interventional cardiology procedures are increasing because they offer many advantages to patients compared with other techniques: therefore the Italian National Institution for Insurance against Accidents at Work decided to start a survey for monitoring the state-of-the-art regarding the professionals involved in those procedures. The survey covered six cardiology and medical physics Italian departments. Each centre was asked to record 10 examinations for five types of procedures: coronary angiography (CA), electrophysiology studies (ES), pacemaker implantation (PI), percutaneous transluminal coronary angioplasty (PTCA) and radiofrequency catheter ablation (RA). For each examination all the centres were requested to fill in a questionnaire containing information regarding the operator performing the examination, the patient and the procedure. A total of 290 examinations were recorded: 103 CA, 14 ES, 68 PI, 79 PTCA and 26 RA. As occupational doses are strongly related to patient doses, both patients and operators radiation dose data are reported. Ratios of maximum to minimum mean patient doses across the hospitals surveyed were 2.0, 3.9, 7.0, 1.8 and 1.4 for CA, ES, PI, PTCA and RA, respectively. The calculated rounded mean dose-area product values across all participating hospitals were comparable with other values reported in the literature. In general, specific radiation protection tools were used by all operators performing different procedures in all hospitals. A major issue in this survey was the absence of information about correlation between staff and patient doses in a single procedure: future studies could be more aimed to prospective goals where occupational exposures per procedure are monitored specifically.

Effective and equivalent organ doses in patients undergoing coronary angiography and percutaneous coronary intervention.

PURPOSE: Recent recommendations of the International Commission on Radiological Protection state that the use of effective dose (E) for assessing patient exposure has severe limitations, though it can be kept for dose comparisons. In cardiology procedures, the equivalent dose (H(T)) is one of the most appropriate dose quantity to be evaluated for risk-benefit assessment. In this study, both E and H(T) values for ten critical organs in coronary angiography (CA) and percutaneous coronary interventions (PCI) were derived from in-the-field dose-area-product (DAP) measurements in order to provide a database for doses in those procedures. METHODS: Conversion factors E/DAP calculated by Monte Carlo methods in two different mathematical human phantoms were applied to DAP values measured on 193 patients (118 CA and 75 PCI). Partial DAP values were recorded in-the-field for each projection and for all patients. The partial effective doses of all projections were summed up to calculate the E of the entire procedure. Similarly, equivalent doses for ten critical organs/tissues (bone, colon, heart, liver, lung, esophagus, red bone marrow, skin, stomach, and thyroid) were derived from H(T)/DAP conversion factors for different projections calculated by Monte Carlo method. RESULTS: All parameters related to the patient dose, i.e., fluoroscopy times, number of images, DAP, effective doses, and equivalent doses, show a wide range of values depending on the complexity of the patient case and the experience of the cardiologist. The mean fluoroscopy time, DAP, and E values for coronary angiography patients were approximately threefold lower than those for PCI patients; the number of images for CA was half that for PCI. The correlation between effective dose and DAP was excellent for both CA and PCI. The equivalent doses values were in good correlations with DAP values in CA examinations, with Pearson's coefficients ranging from 0.87 (stomach) to 0.99 (skin) and r(mean) = 0.94. The same analysis was performed for PCI procedures. In this case, the trends were only slightly worse because "r" ranged from 0.70 (stomach) to 0.92 (bone) and r(mean) = 0.85. Simple conversion coefficients to estimate equivalent doses to ten critical organs/tissues from DAP values, for both CA and PCI, were provided for avoiding the need to carry out detailed in-the-field analysis for all projections and for all patients. CONCLUSIONS: Measurements in-the-field of DAP values were carried out for two common cardiology procedures and effective doses were derived for each technique from detailed analysis of dose and projection data, using conversion factors provided by two different theoretical models. Equivalent doses to organs/tissues were also calculated using conversion factors proposed in the literature for different projections and cumulative conversion factors (H)T/DAP for ten organs/tissues were estimated.

Patient dose in digital projection radiography.

In projection radiography, two types of digital imaging systems are currently available, computed radiography (CR) and direct radiography (DR): a difference between them can be stated in terms of dose and image quality. In the Radiology Emergency Department of our hospital, a flat-panel DR equipment (Siemens Axiom Aristos FX) and two CR systems (Kodak CR-850) are employed. In 2006, five standard radiographic examinations (abdomen, chest, lumbar spine, pelvis, skull) were considered: doses delivered to patients in terms of both entrance skin dose (ESD) and effective dose (E) were calculated and compared in order to study the dosimetric discrepancies between CR and DR. Assessment of image quality is undertaken by Consultant Radiologists to ensure that the quality criteria for diagnostic radiographic images of the European guidelines were met. Results showed that both ESD and E in DR are lower than that in CR; all images met the criteria in the European Guidelines for both modalities and were used for reporting by the radiologists. Since the operators are the same and the image quality is comparable in both modalities, this study shows that in the considered examinations, DR can perform better than CR from a dosimetric point of view.

Effective dose calculations in conventional diagnostic X-ray examinations for adult and paediatric patients in a large Italian hospital.

The effective dose E is an efficient and powerful parameter to study the radioprotection of the patient. In our hospital, eight radiological departments and more than 100 radiological X-ray tubes are present. The effective doses were calculated for adults and paediatric patients in 10 standard projections. To calculate E, first the entrance skin dose (ESD) was evaluated by a mathematical model that was validated by >400 direct measurements taken with an ionisation chamber on four different phantoms: the overall accuracy of the model was better than 12%. Second, to relate ESD to E, conversion coefficients calculated by Monte Carlo techniques were used. The E-values obtained were of the same order as those presented in the literature. Finally, we analysed how the study of E distributions among the various radiological departments can help to optimise the procedures, by identifying the most critical examinations or sub-optimal clinical protocols.

Comparison of six phantoms for entrance skin dose evaluation in 11 standard X-ray examinations.

Entrance skin dose (ESD) is an important parameter for assessing the dose received by a patient in a single radiographic exposure. The most useful way to evaluate ESD is either by direct measurement on phantoms using an ionization chamber or using calculations based on a mathematical model. We compared six phantoms (three anthropomorphic, two physical, and one mathematical) in 11 standard clinical examinations (anterior-posterior (AP) abdomen, posterior-anterior (PA) chest, AP chest, lateral (LAT) chest, AP lumbar spine, LAT lumbar spine, LAT lumbo-sacral joint, AP pelvis, PA skull, LAT skull, and AP urinary tract) for two reasons: to determine the conversion factors to use for ESDs measured on different phantoms and to validate the mathematical model used. First, a comparison was done between the three anthropomorphic phantoms (Alderson Rando, chest RSD-77SPL, and 3M skull) and the two physical phantoms (Uniform and AAPM 31); for each examination we obtained "relative entrance skin dose factors." Second, we compared these five phantoms with the mathematical phantom: the overall accuracy of the model was better than 14%. Total mathematical model and total ionization chamber uncertainties, calculated by quadratic propagation of errors of the single components, were estimated to be on the order of +/-12% and +/-3%, respectively. To reduce the most significant source of uncertainty, the overall accuracy of the model was recalculated using new backscatter factors. The overall accuracy of the model improved: better than 12%. For each examination an anthropomorphic phantom was considered as the gold standard relative to the physical phantoms. In this way, it was possible to analyze the variations in phantom design and characteristics. Finally, the mathematical model was validated by more than 400 measurements taken on different phantoms and using a variety of radiological equipment. We conclude that the mathematical model can be used satisfactorily in ESD evaluations because it optimizes available resources, it is based on direct measurements, and it is an easy dynamic tool.

Usefulness of the (F/T)/PSA density ratio to detect prostate cancer.

INTRODUCTION: Prostate-specific antigen (PSA) is the most important marker in the detection of prostate cancer, but its reliability is limited by a low specificity. To improve the specificity of PSA, a new parameter, based on the combination of free/total PSA (F/T) with PSA density, is proposed. MATERIALS AND METHODS: From April 1999 to June 2003, a series of 647 men with high serum PSA levels were submitted to ultrasound-guided multiple prostate biopsies. Total PSA and free PSA were measured by immunoassay (DASIT, Italy). Receiver operating characteristic (ROC) curves of PSA density, F/T and (F/T)/PSA density (F/T divided by PSA/prostate volume) were constructed, and relative specificity and sensitivity were calculated. RESULTS: Prostate cancer was present in 284 cases (137 of them with PSA values between 4 and 10 ng/ml), 31 patientshad intraepithelial neoplasia and the remaining cases showed benign prostatic hyperplasia. Analysis of ROC curves in all examined patients showed that the area under the curve (AUC) for (F/T)/PSA density (0.849) was significantly higher than the AUC for F/T (0.681) (p = 0.012). Similar results were observed in the cases with PSA levels between 4 and 10 ng/ml, where the AUC for (F/T)/PSA density (0.768) was significantly higher than the AUC for F/T (0.610) (p = 0.041). In our study, the prostate cancer risk became very high when (F/T)/PSA density values decreased to <1.5. CONCLUSION: The use of the (F/T)/PSA density ratio may be useful in the detection of prostate cancer, reducing unnecessary prostate biopsies. A cutoff of 1.5 for the (F/T)/PSA density value is recommended for patients with PSA levels between 4 and 10 ng/ml.

Local diagnostic reference levels in standard X-ray examinations.

The national diagnostic reference levels (NDRLs) form an efficient, concise and powerful standard for optimising radiation protection of a patient. However, in a large hospital, where many radiological departments are present, it is also possible to calculate and define lower dose values as local diagnostic reference levels (LDRLs). In our hospital there are eight radiological departments; in each of these, the entrance skin dose (ESD) distributions were determined for 10 standard projections (AP Abdomen, PA and LAT Chest, AP and LAT Lumbar Spine, LAT Lumbo-Sacral Joint, AP Pelvis, PA and LAT Skull and AP Urinary tract) and then the ESDs were compared with data previously published and with Italian NDRLs. All ESD values were below the corresponding NDRLs. The maximum/minimum ratio of ESDs ranged from 3.9 (LAT Skull) to 34.3 (AP Abdomen) for individual adult patients and from 2.1 (PA Skull) to 6.5 (Urinary tract) across the mean values of the radiological departments. Finally, it is shown how LDRLs can be proposed to obtain a more fully optimised radiation protection of patients.